Inventor · New York, NY, US

Julianne Smith

23Patents
4h-index
28Co-inventors
59Inventor score

Filing activity: Sep 8, 2008 → Dec 21, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7842489B2 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof Chemistry; Metallurgy 44 Active
US10286007B2 Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Chemistry; Metallurgy 10 Active
US10363270B2 Methods for engineering allogeneic and immunosuppressive resistant T cell immunotherapy Chemistry; Metallurgy 5 Active
US10342829B2 Multi-chain chimeric antigen receptor and uses thereof Chemistry; Metallurgy 4 Active
US10378026B2 RNA based method to obtain stably integrated retroviral vectors Chemistry; Metallurgy 4 Active
US10426795B2 Use of preTalpha or functional variant thereof for expanding TCRalpha deficient T cells Chemistry; Metallurgy 4 Active
US10259876B2 Chimeric antigen receptors targeting epidermal growth factor receptor variant III Chemistry; Metallurgy 3 Active
US10874693B2 CD19 specific chimeric antigen receptor and uses thereof Chemistry; Metallurgy 3 Active
US11014989B2 Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy Physics 2 Active
US11077144B2 CD19 specific chimeric antigen receptor and uses thereof Chemistry; Metallurgy 2 Active
US11944643B2 Universal anti-CD22 chimeric antigen receptor engineered immune cells Chemistry; Metallurgy 1 Active
US11603539B2 Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapy Chemistry; Metallurgy 0 Active
US10752670B2 Anti-GD3 specific chimeric antigen receptors for cancer immunotherapy Chemistry; Metallurgy 0 Active
US11274316B2 Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Chemistry; Metallurgy 0 Active
US9273296B2 Meganuclease variants cleaving a DNA target sequence from a glutamine synthetase gene and uses thereof Human Necessities 0 Active
US11304975B2 Methods for engineering allogeneic and highly active t cell for immunotherapy Chemistry; Metallurgy 0 Active
US12133867B2 Universal anti-CD22 chimeric antigen receptor engineered immune cells Chemistry; Metallurgy 0 Active
US11311575B2 Methods for engineering highly active T cell for immunotherapy Chemistry; Metallurgy 0 Active
US11007224B2 CD19 specific chimeric antigen receptor and uses thereof Chemistry; Metallurgy 0 Active
US11267892B2 Chimeric antigen receptors targeting epidermal growth factor receptor variant III Chemistry; Metallurgy 0 Active
US11891614B2 Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapy Chemistry; Metallurgy 0 Active
US10517896B2 Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Chemistry; Metallurgy 0 Active
US11414674B2 Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.